The Weill Cornell cohort study (255 GLP-1RA subjects, 92% women, mean age 64) found that greater annualized hip bone loss was concentrated in patients without diabetes - exactly the demographic of postmenopausal women using GLP-1s purely for weight management
OR To continue reading Password required to log in Disease-Modifying Therapies The main goal of the treatment of multiple sclerosis (MS) is to decrease relapse frequency and slow the progression of disability
Medica Depot connects licensed researchers with sourcing guidance and documentation support from verified research-grade suppliers
Jo D, Choi SY, Ahn SY, Song J (2025) IGF1 enhances memory function in obese mice and stabilizes the neural structure under insulin resistance via AKT-GSK3-BDNF signaling
Launched in 1971, Work Right Products opened its first Lake County plant a year later, making glass shower enclosures
It is licensed only for type 2 diabetes mellitus and carries risks including loss of lean muscle mass, gastrointestinal disturbances, fatigue, and potential hypoglycaemia, all of which impair athletic performance and training capacity
